HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Grouzmann, E. Articles by Buclin, T. Search for Related Content PubMed PubMed Citation Articles by Grouzmann, E. Articles by Buclin, T. Related Collections Endocrinology and Metabolism

Disappearance Rate of Catecholamines, Total Metanephrines, and Neuropeptide Y from the Plasma of Patients after Resection of Pheochromocytoma

¹ Division d’Hypertension,
² Pharmacologie Clinique, and
³ Service de Chirurgie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.

⁴ Hôpital Communal, 2300 la Chaux-de-Fonds, Switzerland.

⁵ Laboratoire Central de Chimie Clinique, Hôpital Cantonal Universitaire de Genève, 1211 Geneva, Switzerland.

^aAddress correspondence to this author at: Division of Hypertension, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Fax 41-21-3140761; e-mail eric.grouzmann{at}chuv.hospvd.ch.

Background: Plasma free metanephrines are a more reliable analyte to measure than catecholamines for the biochemical diagnosis of pheochromocytomas. We hypothesized that the long persistence of total (sulfate-conjugated plus free) metanephrines in the blood might have a significant diagnostic value.

Methods: We measured plasma concentrations of catecholamines and total metanephrines (sulfate-conjugated plus free forms) by HPLC with amperometric detection, and neuropeptide Y (NPY) by an amplified ELISA in seven patients before and after removal of their pheochromocytomas. The results for catecholamine, total metanephrines, and NPY in each patient were analyzed for up to 120 min, starting from the time of tumor vessel clamping. The persistence of analytes was quantified as the area under the concentration–time curve over 120 min.

Results: On the basis of the upper reference limit for each variable, plasma free norepinephrine (NE) and epinephrine (E) concentrations were increased preoperatively in at least one sample in seven and six patients, respectively. Total normetanephrine (NMN) and metanephrine (MN) were increased in all samples in seven and six patients, respectively. NPY was increased 2- to 465-fold. After removal of the tumor, MN and NMN showed a higher average relative increase above the upper limit of the reference interval than NE and E (P = 0.05), whereas NPY was intermediate. The persistence of increased values was significantly shorter for catecholamines than for metanephrines. The half-life estimated by nonlinear regression was 12.3 ± 7.8 min for NPY. Significant correlations were observed among NE, E, NMN, MN, and NPY concentrations, but parent markers (E and MN or NE and NMN) did not appear significantly intercorrelated.

Conclusions: A larger increase and a longer persistence of total metanephrines (reflecting predominantly sulfo-conjugated metanephrines) than catecholamines and NPY in plasma may contribute to their greater diagnostic accuracy in pheochromocytoma.

The following articles in journals at HighWire Press have cited this article:

				T. Yoshida, T. Hibino, N. Kako, S. Murai, M. Oguri, K. Kato, K. Yajima, N. Ohte, K. Yokoi, and G. Kimura A pathophysiologic study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography Eur. Heart J., November 1, 2007; 28(21): 2598 - 2604. [Abstract] [Full Text] [PDF]

				S. Cleary, J. K Phillips, T.-T. Huynh, K. Pacak, A. G Elkahloun, J. Barb, R. A Worrell, D. S Goldstein, and G. Eisenhofer Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome J. Endocrinol., May 1, 2007; 193(2): 225 - 233. [Abstract] [Full Text] [PDF]

				I. S. Wittstein, D. R. Thiemann, J. A.C. Lima, K. L. Baughman, S. P. Schulman, G. Gerstenblith, K. C. Wu, J. J. Rade, T. J. Bivalacqua, and H. C. Champion Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress N. Engl. J. Med., February 10, 2005; 352(6): 539 - 548. [Abstract] [Full Text] [PDF]

				S. A. Lagerstedt, D. J. O'Kane, and R. J. Singh Measurement of Plasma Free Metanephrine and Normetanephrine by Liquid Chromatography-Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma Clin. Chem., March 1, 2004; 50(3): 603 - 611. [Abstract] [Full Text] [PDF]

				R. L. Taylor and R. J. Singh Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Analysis of Urinary Conjugated Metanephrine and Normetanephrine for Screening of Pheochromocytoma Clin. Chem., March 1, 2002; 48(3): 533 - 539. [Abstract] [Full Text] [PDF]

				G. Eisenhofer Free or Total Metanephrines for Diagnosis of Pheochromocytoma: What Is the Difference? Clin. Chem., June 1, 2001; 47(6): 988 - 989. [Full Text] [PDF]